Stockscreener 앱 받기
27.00
5.22%
1.34
시간 외 거래:
27.05
0.05
+0.19%
전일 마감가:
$25.66
열려 있는:
$25.58
하루 거래량:
1.54M
Relative Volume:
1.76
시가총액:
$3.04B
수익:
$14.09M
순이익/손실:
$-176.94M
주가수익비율:
-12.56
EPS:
-2.15
순현금흐름:
$-141.24M
1주 성능:
+12.27%
1개월 성능:
+24.25%
6개월 성능:
+17.29%
1년 성능:
+66.67%
1일 변동 폭
$25.16
$27.05
1주일 범위
$23.98
$27.05
52주 변동 폭
$14.06
$27.29
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
명칭
Newamsterdam Pharma Company Nv
전화
35 206 2971
주소
GOOIMEER 2-35, NARRDEN
NAMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
27.00 | 2.89B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 개시 | Wells Fargo | Overweight |
| 2025-07-17 | 개시 | Goldman | Neutral |
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2025-06-10 | 개시 | Stifel | Buy |
| 2025-06-04 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-05-15 | 개시 | TD Cowen | Buy |
| 2024-03-14 | 개시 | Scotiabank | Sector Outperform |
| 2024-01-18 | 개시 | Guggenheim | Buy |
| 2024-01-16 | 개시 | Piper Sandler | Overweight |
| 2023-10-30 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Newamsterdam Pharma Company Nv 주식(NAMS)의 최신 뉴스
Best data tools to analyze NewAmsterdam Pharma Company N.V. stock2025 Geopolitical Influence & Intraday High Probability Alerts - Newser
What to expect from NewAmsterdam Pharma Company N.V. Equity Warrant in the next 30 daysPortfolio Update Summary & AI Enhanced Trading Signals - Newser
Is NewAmsterdam Pharma Company N.V. Equity Warrant on track to beat earningsJuly 2025 PostEarnings & Target Return Focused Picks - خودرو بانک
What’s the outlook for NewAmsterdam Pharma Company N.V.’s sector2025 Sector Review & Daily Chart Pattern Signals - خودرو بانک
Is NewAmsterdam Pharma Company N.V. subject to activist investor interestEarnings Growth Report & High Conviction Buy Zone Picks - خودرو بانک
Can NewAmsterdam Pharma Company N.V. Equity Warrant reach resistance levels soon2025 Buyback Activity & Precise Trade Entry Recommendations - خودرو بانک
Can NewAmsterdam Pharma Company N.V. Equity Warrant weather a recessionWeekly Investment Recap & Daily Price Action Insights - خودرو بانک
Technical signs of recovery in NewAmsterdam Pharma Company N.V. Equity WarrantGap Down & Fast Entry and Exit Trade Plans - Newser
Can trapped investors hope for a rebound in NewAmsterdam Pharma Company N.V.July 2025 Institutional & Intraday High Probability Alerts - Newser
What’s the MACD signal for NewAmsterdam Pharma Company N.V. Equity Warrant2025 Key Highlights & Real-Time Price Movement Reports - خودرو بانک
Will NewAmsterdam Pharma Company N.V. rebound enough to break evenEarnings Miss & Community Supported Trade Ideas - Newser
How to build a custom watchlist for NewAmsterdam Pharma Company N.V. Equity Warrant2025 Volume Leaders & Accurate Technical Buy Alerts - Newser
What to do if you’re stuck in NewAmsterdam Pharma Company N.V. Equity WarrantEarnings Growth Summary & Expert Curated Trade Setup Alerts - Newser
What are the future prospects of NewAmsterdam Pharma Company N.V.Weekly Trade Report & AI Forecasted Stock Moves - خودرو بانک
Can swing trading help recover from NewAmsterdam Pharma Company N.V. Equity Warrant lossesJuly 2025 Technicals & Community Supported Trade Ideas - Newser
Analyzing NewAmsterdam Pharma Company N.V. with risk reward ratio chartsJuly 2025 Momentum & Safe Capital Growth Trade Ideas - Newser
Applying Elliott Wave Theory to NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Rallies & Intraday High Probability Alerts - Newser
Using fundamentals and technicals on NewAmsterdam Pharma Company N.V.Market Risk Analysis & Consistent Profit Trading Strategies - Newser
Does NewAmsterdam Pharma Company N.V. have pricing powerJuly 2025 Chart Watch & Comprehensive Market Scan Reports - خودرو بانک
Historical volatility pattern of NewAmsterdam Pharma Company N.V. visualizedLayoff News & High Conviction Buy Zone Picks - Newser
What candlestick patterns are forming on NewAmsterdam Pharma Company N.V.July 2025 Setups & AI Powered Market Entry Ideas - Newser
Will NewAmsterdam Pharma Company N.V. Equity Warrant benefit from macro trendsWeekly Trade Review & Daily Profit Maximizing Tips - Newser
NewAmsterdam Pharma Company N.V. stock prediction for this weekJuly 2025 Update & Short-Term Swing Trade Alerts - Newser
How sentiment analysis helps forecast NewAmsterdam Pharma Company N.V. Equity WarrantNew Guidance & Intraday High Probability Alerts - Newser
Sector ETF performance correlation with NewAmsterdam Pharma Company N.V. Equity WarrantCEO Change & Safe Capital Preservation Plans - Newser
NewAmsterdam Pharma Company N.V.’s volatility index tracking explainedJuly 2025 Opening Moves & Fast Moving Trade Plans - Newser
Published on: 2025-09-04 02:08:48 - Newser
Predicting NewAmsterdam Pharma Company N.V. trend using moving averagesOptions Play & Precise Trade Entry Recommendations - Newser
Jefferies Remains Bullish on NewAmsterdam Pharma (NAMS) - MSN
How much upside does NewAmsterdam Pharma Company N.V. Equity Warrant haveJuly 2025 Snapshot & Accurate Buy Signal Notifications - خودرو بانک
Evaluating NewAmsterdam Pharma Company N.V. with trendline analysisGold Moves & Fast Exit and Entry Strategy Plans - Newser
Does NewAmsterdam Pharma Company N.V. Equity Warrant align with a passive investing strategyMarket Sentiment Report & Daily Entry Point Alerts - خودرو بانک
Using RSI to spot recovery in NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - Newser
What earnings revisions data tells us about NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Opening Moves & Community Consensus Stock Picks - Newser
Is NewAmsterdam Pharma Company N.V. Equity Warrant a momentum stockVolume Spike & Real-Time Stock Movement Alerts - خودرو بانک
Published on: 2025-09-03 00:34:38 - Newser
A | Is NewAmsterdam Pharma Company N.V. stock good for income investorsWeekly Trading Summary & Verified Technical Signals - خودرو بانک
Analyzing drawdowns of NewAmsterdam Pharma Company N.V. with statistical toolsJuly 2025 Patterns & Technical Confirmation Trade Alerts - Newser
Using Ichimoku Cloud for NewAmsterdam Pharma Company N.V. Equity Warrant technicalsJuly 2025 Catalysts & Weekly Momentum Picks - Newser
Real time breakdown of NewAmsterdam Pharma Company N.V. stock performanceMarket Activity Summary & Fast Exit/Entry Strategy Plans - Newser
Is NewAmsterdam Pharma Company N.V. Equity Warrant forming higher highs and higher lowsWeekly Investment Summary & Free AI Powered Buy and Sell Recommendations - خودرو بانک
Sector ETF performance correlation with NewAmsterdam Pharma Company N.V.July 2025 PostEarnings & Detailed Earnings Play Strategies - Newser
How to monitor NewAmsterdam Pharma Company N.V. with trend dashboards2025 Investor Takeaways & Stock Portfolio Risk Management - Newser
What is NewAmsterdam Pharma Company N.V. Equity Warrant s debt to equity ratio2025 Earnings Surprises & Accurate Buy Signal Notifications - 한국정경신문
NewAmsterdam Pharma Highlights Progress in Obicetrapib Trials - TipRanks
Newamsterdam Pharma Company Nv (NAMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):